Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01002456 · ClinicalTrials.gov registry record · NA
Beta-Blockers in Heart Failure: Pharmacy-level Intervention Comparison
A NA study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- NA
- Development phase
- 220
- Enrollment target
NCT01002456: Completed NA study, sponsored by US Department of Veterans Affairs.
NCT01002456 is a NA study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 220 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01002456, a NA study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- NA
- Development phase
- 220 participants
- Enrollment target
Study Summary
The overall objective of the proposed pilot study is to begin evaluation of two methods for promoting adherence to guidelines for beta-blocker therapy in heart failure. The design includes site level baseline measurement, feedback, remeasurement after six months, and randomized (by site) comparison samples. The setting is VA sites, with intervention directed at the pharmacy.
Primary Outcome
full adherence to guideline medication and dose
Interventions
- OTHER Level 1: (provide site-specifi information)
- OTHER Level 2 (Provide site- and patient-specific information)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 220 participants |
| Start Date | 2009-10 |
| Est. Completion | 2012-10 |
| Phase | NA |
What the finished NCT01002456 record still lists
NCT01002456 is an interventional study that assigns participants to a tested intervention. The registered 220 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower).
The record links to 0 conditions, and to 2 interventions - of which Level 1: (provide site-specifi information) is the first listed.
NCT01002456 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01002456 about?
NCT01002456 is a clinical study titled "Beta-Blockers in Heart Failure: Pharmacy-level Intervention Comparison". The overall objective of the proposed pilot study is to begin evaluation of two methods for promoting adherence to guidelines for beta-blocker therapy in heart failure. The design includes site level baseline measurement, feedback, remeasurement after six months, and randomized (by site) comparison ...
What is the current status of trial NCT01002456?
This trial is currently completed. It is a NA study. The enrollment target is 220 participants. The study started on 2009-10. Estimated completion is 2012-10.
What interventions are being tested in trial NCT01002456?
The interventions under investigation include: Level 1: (provide site-specifi information) (OTHER), Level 2 (Provide site- and patient-specific information) (OTHER).
Who is sponsoring clinical trial NCT01002456?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01002456's enrollment target sits among peer trials
220 481st of 2000 higher than 1,516 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00920972 · 220 participants · Phase 1
Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases
- NCT01851642 · 220 participants
Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs
- NCT02582021 · 220 participants
WISE CVD - Continuation (WISE HFpEF)
- NCT04067830 · 220 participants · Phase 2
Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia